Delivery Order SPE2DR25D9239-SPE2DR26FFBP1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,338.41 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 20 mg tablets (60-count units). This firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of October 30, 2025, and does not utilize a set-aside designation. The award reflects DMS Pharmaceutical Group's competitive capability to...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation, demonstrating the contractor's ability to compete effectively in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of JAKAFI 5 mg tablets (60-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The ultimate completion date is November 19, 2025, with...
- The Defense Logistics Agency awarded a $54,115.79 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of JAKAFI 10 mg. The award, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, was awarded without set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order was awarded on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a routine pharmaceutical supply transaction without set-aside designation. The award was issued under DMS...
- The Defense Logistics Agency (DLA) awarded a $99,172.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of JAKAFI 5 mg. This delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 13, 2025, was not set aside for any particular business category. DMS Pharmaceutical Group will perform under this order from...
- The Defense Logistics Agency awarded a delivery order valued at $24,676.82 to DMS Pharmaceutical Group Inc. for 60 tablets of JAKAFI 20 mg, a prescription medication used in the treatment of certain blood disorders and cancers. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected through firm fixed-price pricing with an ultimate completion date of December 4, 2025. The award carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $49,586.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The contract is funded by the...
- SPE2DR25D9239Indefinite Delivery Contract
- SPE2DR25D9239-SPE2DR26FFBP1Delivery Order
The Defense Logistics Agency awarded a $258,404.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). The delivery order, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. DMS Pharmaceutical Group Inc. is performing at the place of performance in Park Ridge, Illinois, with no identified subcontractors on this award. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, valued at $499.99 billion with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products to support Department of Defense medical supply requirements globally. DMS Pharmaceutical Group's established performance across numerous delivery orders and its extensive product portfolio spanning oncology treatments, biologics, specialty pharmaceuticals, and routine medications position the company as a critical supplier within the federal military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $258.4k | 12/3/25 |